Tag: TCAR
InspireMD receives IDE approval from US FDA for CGUARDIANS II pivotal...
InspireMD has announced the US Food and Drug Administration (FDA) approval of the company’s investigational device exemption (IDE) application to initiate the CGUARDIANS II...
Boston Scientific completes acquisition of Silk Road Medical
Boston Scientific announced the close of its acquisition of Silk Road Medical, the company behind transcarotid artery revascularisation (TCAR).
"The integration of the TCAR platform into our portfolio...
Vascular News’ top 10 most popular stories of July 2024
Several company updates including Series A funding for Endoron Medical, new insights on the role of machine learning in determining endovascular aneurysm repair (EVAR)...
Silk Road celebrates milestone of 100,000 TCAR procedures
Silk Road Medical has announced the milestone of more than 100,000 transcarotid artery revascularisation (TCAR) procedures having been performed to date.
“A growing number of...
CEA and TCAR should be “first-line” interventions for weekend carotid revascularisation,...
Patients who undergo carotid revascularisation at the weekend have increased odds of complications and mortality, with transfemoral carotid artery stenting (TFCAS) posing the highest...
Patient selection may explain “counterintuitive” relationship between carotid stenting volume and...
High stroke and death rates relating to carotid stenting in the Pacific Northwest may be driven by the selection of high-risk patients with less...
TCAR and endarterectomy both “reasonable” but stenting linked to worse outcomes...
A study examining outcomes between different carotid revascularisation procedures has concluded that transcarotid artery revascularisation (TCAR) and carotid endarterectomy (CEA) both represent a “reasonable...
Boston Scientific announces agreement to acquire Silk Road Medical
Boston Scientific has announced that it has entered into a definitive agreement to acquire Silk Road Medical, a medical device company involved in producing...
Vascular News’ top 10 most popular stories of March 2024
Transcarotid artery revascularisation (TCAR) features in three of March's most popular Vascular News stories, with a talk on the future of aortic repair and...
Silk Road adds Enroute NPS Plus device to TCAR portfolio
Silk Road Medical has announced the launch of its Enroute transcarotid neuroprotection system Plus (NPS Plus), which the company describes as a key component...
Single-centre analysis suggests improved longer-term outcomes with endarterectomy versus TCAR
A large, single-centre analysis has found that, despite parity between the two procedures in terms of perioperative clinical outcomes, carotid endarterectomy (CEA) was associated...
Silk Road expands TCAR portfolio with launch of tapered Enroute system
Silk Road Medical has announced the launch of its tapered Enroute transcarotid stent system to hospitals in the USA, expanding upon the company’s prior...
ISC 2024 examines TCAR ‘explosion’ alongside advances in intensive medical therapy
This year’s International Stroke Conference (ISC; 7–9 February, Phoenix, USA) hosted discussions on the current state of play in carotid stenosis treatment—and, most notably,...
Peter Schneider
Peter Schneider (University of California San Francisco, San Francisco, USA) speaks to Vascular News about his life and career. Trained during the era of...
Rates of stroke, death and myocardial infarction post-TCAR do not differ...
While sex disparities regarding the outcomes of carotid revascularisation have “long been a concern”, new prospective data published in the Journal of Vascular Surgery...
Vascular News’ top 10 most popular stories of April 2023
April's top 10 sees a product announcement from Terumo Aortic take the top spot, with highlights from the 2023 Charing Cross (CX) International Symposium...
Vascular community split over “death” of traditional carotid stenting
A debate between two prominent carotid interventionists—Peter Schneider (University of California San Francisco, San Francisco, USA) and Domenico Valenti (King's College London, London, UK)—at...
Initial cases indicate lithotripsy can help TCAR expand into high-risk patients
Lithotripsy may hold the key to enabling more carotid artery disease patients who require calcification treatment to undergo stent placement via a transcarotid artery...
Dual antiplatelet therapy linked to better post-TCAR outcomes versus other drug...
Dual antiplatelet therapy (DAPT) has demonstrated improved clinical outcomes, including reduced in-hospital stroke and mortality risks, compared to other medication regimens in carotid artery...
TCAR and the treatment of asymptomatic patients hot topics for discussion...
Barbara Rantner (Munich, Germany) talks about the “fantastic experience” of being back in person at CX 2022, where she notes that attendees were able...
Endarterectomy and TCAR “continue to show superior outcomes” to transfemoral stenting
Researchers led by a vascular team in Indianapolis found that carotid endarterectomy (CEA) remains the most-used strategy in carotid revascularisation, with CEA and transcarotid...
Silk Road Medical announces first patient enrolled in ROADSTER 3 post-approval...
Silk Road Medical has announced enrolment of the first patient in ROADSTER 3, which the company claims is the the first prospective, multicentre, single-arm...
Silk Road to evaluate TCAR in standard surgical risk patients with...
Silk Road Medical today announced a post-market study to evaluate the transcarotid artery revascularisation (TCAR) system in the treatment of standard surgical risk patients...
Silk Road Medical announces expanded Medicare coverage for TCAR in standard...
Silk Road Medical recently announced that the Centers for Medicare and Medicaid Services (CMS), through collaboration with the Society of Vascular Surgery’s Patient Safety...
Silk Road Medical announces FDA approval of expanded indications for the...
Silk Road Medical recently announced that the US Food and Drug Administration (FDA) approved expanded indications for the company's Enroute stent to include patients...
Vascular News’ top 10 most popular stories of February 2022
February's top 10 includes a consensus statement from the Society for Vascular Surgery (SVS) and the Enhanced Recovery after Surgery (ERAS) Society on perioperative...
Worldwide TCAR analysis provides “roadmap” to evaluate future training approaches
An analysis of the worldwide experience of transcarotid artery revascularisation (TCAR) has produced key objective proficiency metrics and an analytic framework to assess adequate...
Vascular News’ top 10 most popular stories of January 2022
Breakthrough designation for a new drug-eluting stent from Cook Medical, a meta-analysis on the safety of expedited carotid artery surgery vs. expedited stenting after...
Cost-effectiveness of TCAR versus carotid endarterectomy addressed in new study
A cost-effectiveness model based on peer-reviewed sources suggests that although five-year costs for transcarotid artery revascularisation (TCAR; Silk Road Medical) were higher than those for...
TCAR may be associated with favourable outcomes for treatment of restenotic...
Transcarotid artery revascularisation (TCAR; Silk Road Medical) may be associated with favourable in-hospital outcomes for the treatment of restenotic carotid lesions after carotid endarterectomy...
Vascular News’ top 10 most popular stories of August 2021
Research presented at the Society for Vascular Surgery’s Vascular Annual Meeting (SVS VAM 2021; 18–21 August, San Diego, USA and online)—including new VOYAGER PAD...
First ever analysis of TCAR in standard surgical risk patients demonstrates...
Silk Road Medical has announced positive results from an independent analysis of standard surgical risk patients undergoing carotid endarterectomy (CEA) and transcarotid artery revascularisation...
TCAR associated with “promising early and late outcomes”, pooled data suggest
A systematic review and meta-analysis has found that transcarotid artery revascularisation (TCAR) is associated with “promising early and late outcomes” in patients with internal...
Study finds hospital availability of TCAR associated with an improvement in...
Positive results from a comparative-effectiveness study involving transcarotid artery revascularisation (TCAR) have been published in JAMA Network Open, Silk Road Medical have announced.
The study...
Compelling outcomes with TCAR versus CEA in patients with carotid artery...
Silk Road Medical has announced that positive results from the ongoing TransCarotid Artery Revascularisation (TCAR) Surveillance Project, comparing TCAR with carotid endarterectomy (CEA), have...
TCAR a “phenomenal alternative” to carotid endarterectomy for high-risk patients
Keith Calligaro (Philadelphia, USA) interviews Vikram Kashyap (Cleveland, USA) for VEITHtv at VEITHsymposium 2019 (19–23 November, New York, USA) about whether transcarotid artery revascularisation (TCAR) might replace carotid...
TCAR “combines best of both worlds” but carotid endarterectomy “remains the...
Ali AbuRahma (Charleston, USA) moderates a panel for VEITHtv where he is joined by Mahmoud Malas (San Diego, USA) and Enrico Ascher (New York, USA), to...
Favorable outcomes with TCAR versus carotid endarterectomy in patients with carotid...
Silk Road Medical announced the presentation of real-world data for the treatment of patients with carotid artery disease at risk for stroke at the...
Reimbursement for CAS in the USA could be tied to accountability
Recent technological advancements, including the use of micromesh stents, greater adoption of proximal protection and new techniques such as transcarotid artery revascularisation (TCAR) are taking...
Transcarotid artery revascularisation suggests reduced risk of major adverse events compared...
Real-world outcomes from the Transcarotid Artery Revascularisation (TCAR) Surveillance Project (TSP) were presented by Mahmoud Malas from John Hopkins Hospital (Baltimore, USA) at the...
Similar in-hospital major outcomes of TCAR and carotid endarterectomy
Major adverse events in patients undergoing transcarotid artery revascularisation (TCAR) were similar to those receiving a carotid endarterectomy, a study has found, despite the...
Comparable results found for transcarotid artery revascularisation and CEA at VEITH...
Silk Road Medical data presented at the VEITH Symposium have found comparable results for transcarotid artery revascularisation (TCAR) and carotid endarterectomy (CEA), among other...
